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Since its discovery in 1916, heparin has been used extensively for
treatment of thromboembolic disorders. Bleeding is its most well-
known and frequent complication. We are describing the first case
report of overt pulmonary hemorrhage in a patient who received
heparin after emergent angioplasty forprevention of coronaryartery
rethrombosis.
Bleeding is a well-known complication of heparin therapy but
spontaneous overt hemorrhage in the lungs following heparin has
not been described. The following report describes a case of
spontaneous pulmonary hemorrhage that developed after heparin
therapy in a patient who underwent angioplasty for his acute
myocardial infarction (MI).
Case Report
A 72-year-old man was admitted to the emergency room 30
minutes after the acute onset of severe substernal chest pain. He had
a history of end-stage renal disease and hypertension and had been
on continous ambulatory peritoneal dialysis for the past 10 months.
His blood pressure had been well controlled for the past year without
any medication. There was no significant history of respiratory
disease except for a right rib fracture sustained as a teenager. There
was no history of any bleeding disorder. He had not smoked for
more than 30 years and medications prior to admission were epoetin
alpha (Epogen) and multivitamin supplement.
Upon arrival, his blood pressure was 122/72 mmHg with pulse
rate of 76/mm, respiratory rate at 20/mm and temperature of 98°F.
The physical examination revealed a well-developed man in mod
erate distress but was otherwise unremarkable. ECG demonstrated
hyperacute ST elevation over leads V2 to V5. He was given 325 mg
of aspirin and underwent emergent cardiac catheterization.
Angiography showed a 95% stenosis of his left anterior descending
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coronary artery, which was treated with immediate angioplasty,
resulting in a residual 25% lesion. A bolus dose of 10,000 units
intravenous heparmn was given prior to angioplasty; followed by
continous infusion at 800 units/hr. Within the next 30 minutes, he
developed an episode of hemoptysis and heparin infusion was
stopped immediately. A Swan-Ganz pulmonary artery catheter was
placed and the initial reading of his pulmonary artery pressure was
29/11 mmHg with pulmonary capillary wedge pressure of 17
mmHg and cardiac index of 3.1 L/minlm2His hemoptysis resolved
the following two hours, at which time heparin infusion was
resumed.
Initial laboratory results were hemoglobin 10.2 g/dl; hematocrit
30.2 %; white count 13,500/mm;platelet 265,000/mm3;blood urea
nitrogen 64 mg/dl; creatinine 3.8 mgldl; prothrombin time (PT) 12.0
s (control 10 to 13 s); and activated partial thromboplastin time
(PTT) 25.4 s. Arterial blood gas taken on room air showed pH 7.36,
Pco2 44 mmHg, Po2 74.2 mmHg, oxygen saturation 92.7 %. Chest
x-ray showed calcification of the posterior right pleural space, but
was otherwise normal.
After heparmn infusion was restarted, he developed hemoptysis
again, which progressively worsened so that heparin had to be
stopped. Repeat PTT three hours after the initial bolus dose was 92
s and it normalized within the next four hours. The bleeding time
then was 9 minutes (upper limit of normal 9 mm) and platelet count
was 104 000/mm3.Despite normal coagulation studies, he contin
ued having hemoptysis for the next two days, dropping his hemo
globin level to 8.1 g/dl. He was intubated at the time of his
respiratory distress. Bronchoscopy was performed which showed
presence of large blood clots in the airways. He required transfusion
of 5 units of packed red blood cells to maintain his hemoglobin
above 10.0 g/dl. His chest x-ray showed pulmonary infiltrates
which worsened over the following few days (Fig 1). He responded
to supportive measures and his condition gradually improved. He
was extubated on his sixth day post MI. Repeat bronchoscopy
before extubation revealed presence ofblood clots. No endobronchial
lesion was seen. The patient was finally discharged from the
hospital on the fourteenth day post MI after successfully undergoing
cardiac rehabilitation protocol and repeat angiogram, which showed
that his coronary artery lesion had remained patent.
Discussion
Heparmn has been used in the treatment of unstable angina and
acuteMIas adjunct treatment to emergent angioplasty orthrombolytic
therapy.’ The most common side effect is bleeding. The lung is not
usually known to be a potential site of bleeding. This is the first case
report of a spontaneous, overt pulmonary hemorrhage following
heparin therapy. A case of occult pulmonary hemorrhage following
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/ Fig 1.—Chest x-ray
heparin therapy has been described earlier by Finley and col
leagues.2
There have been three case reports in the English literature
documenting pulmonary hemorrhage as a complication following
thrombolytic therapy. In all three cases, the diagnosis was made
based on the triad of hemoptysis, falling hemoglobin, and new
pulmonary infiltrate on x-rays. Awadh and colleagues described a
patient with pulmonary hemorrhage following streptokinase and
heparin therapy.3 Both streptokinase and heparin therapies may
have contributed to the bleeding. Disler and Rosendorff’ reported a
case ofpulmonary hemorrhage following intravenous streptokinase
in a patient who had recently recovered from a lower respiratory
tract infection. An unresolved pneumonia was implicated to have
contributed to this complication. Nathan et al° described a similar
case of pulmonary hemorrhage following thrombolytic therapy and
in their case the patient had a Swan-Ganz pulmonary artery catheter
placed prior to the onset of the hemoptysis. Thrombolytic therapy
and the catheter may have contributed to this complication. Our
patient received only heparmn therapy, had no prior history of
pneumonia or any lung disease, and developed an episode of
hemoptysis prior to insertion of the pulmonary catheter, the proper
position of which was confirmed radiologically. Continous moni
toring of the wedge pressure did not show dampening
to suggest overwedging.
There are two mechanisms whereby heparmn is
eliminated from the body. There is the rapid clearance
by binding of heparin to receptors on endothelial cells
and macrophages, whereby it is internalized and depo
lymerized. And the other is a slower mechanism of
clearance which is mainly renal.’ Renal failure is a
known risk factor for heparmn-associated bleeding.6
However, in the presence of decreased renal clearance,
hemostatic abnormalities such as prolonged bleeding
time, impaired platelet adhesion or aggregration are
usually reversible following dialysis. Age also has been
shown to increase the incidence of bleeding with hep
arm use as demonstrated in a study by lick et al7 but the
underlying mechanism of which is not well defined.
Renal impairment and advanced age may have played
a significant role in the development of spontaneous
pulmonary hemorrhage in our patient.
Even though pulmonary hemorrhage is a clinical
diagnosis based on the presence of hemoptysis, new
radiographic pulmonary infiltrate, and falling hemo
globin; occult pulmonary hemorrhage without
hemoptysis has been described.2Therefore this diagno
sis should be kept in mind when dealing with patients
who had thrombolytic and/or heparin therapy with
progressive anemia. Magnetic resonance imaging (MRI)
and diffusion capacity of carbon monoxide gas (DLco)
have been described to aid in diagnosing the presence
of blood in lung parenchyma. Both methods require
specialized equipment and patients’ cooperation which
are not easily suitable for unstable patients.
Bronchoscopy with bronchoalveolar lavage would be a
more helpful tool in confirming the diagnosis. Hemo
siderin score (an arbitrary score of hemosiderin content
present in the mean of 100 macrophages) has been
described to aid in the diagnosis, especially in occult
hemorrhage.2
Conclusion
In summary, we report the first case of spontane
ous overt pulmonary hemorrhage following heparin therapy. The
patient’s advanced age and renal condition have contributed to this
complication. Heparin should therefore be used with caution in
elderly renal patients. Awareness of this potential complication
may help minimize the morbidity and mortality inherently present
with its use.
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